Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model

BACKGROUND: Fesoterodine, a new once daily antimuscarinic, has proven to be an effective, safe, and well-tolerated treatment in patients with overactive bladder (OAB). To date, no analysis has evaluated the economic costs and benefits associated with fesoterodine, compared to antimuscarinics in Spai...

Descripción completa

Detalles Bibliográficos
Autores principales: Arlandis-Guzman, Salvador, Errando-Smet, Carlos, Trocio, Jeffrey, Arumi, Daniel, Rejas, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126790/
https://www.ncbi.nlm.nih.gov/pubmed/21599928
http://dx.doi.org/10.1186/1471-2490-11-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126790/
https://www.ncbi.nlm.nih.gov/pubmed/21599928
http://dx.doi.org/10.1186/1471-2490-11-9

Ejemplares similares